Jeff Garro

Q: What is Jeff Garro's success rate?

Jeff Garro currently has a success rate of 100.

Q: What is the average return of Jeff Garro's calls?

Their stock ratings have generated an average return of 46.39758739402502.

Stephens & Co. | Healthcare

Jeff Garro is an analyst from Stephens & Co. specializing in the Healthcare sector. Ranked #248 out of 4773 analysts, they have issued 13 stock ratings with a success rate of 100.00% and an average return of 46.40%.

With 13 ratings to date, Jeff Garro is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 100.00% and an average return of 46.40%, highlighting promising potential as their track record develops further.

#248

Out of 4773

Total Ratings

+100.00%

Success Rate

+46.40%

Average Return

Recent Ratings Analysis

OPRX

Hold

May 13, 2026

Target

$7.00

Current

$7.29

Performance

48.17%

Jeff Garro rated OPRX as Equal-Weight on May 13, 2026, setting a price target of 7. Despite the Hold call, shares climbed 48.17% to 7.29, revealing unexpected momentum.

HCAT

Hold

May 12, 2026

Target

$1.75

Current

$1.70

Performance

14.86%

On May 12, 2026, HCAT was given a Equal-Weight rating by Jeff Garro, with a target price of 1.75. The stock rallied from 1.7 to 1.7 after the Hold rating, surprising to the upside.

CERT

Buy

May 12, 2026

Target

$9.00

Current

$7.55

Performance

48.33%

CERT received a Overweight rating from Jeff Garro on May 12, 2026, aiming for 9. Momentum has favored the Buy call, with shares climbing from 7.55 to 7.55, rewarding those who trusted the recommendation.

TBRG

Hold

Apr 01, 2026

Target

$18.00

Current

$26.24

Performance

67.67%

On Apr 01, 2026, Jeff Garro published a Equal-Weight outlook on TBRG, with a target of 18. The Hold call missed some of the bullish momentum as shares advanced toward 18.

PHR

Buy

Mar 31, 2026

Target

$20.00

Current

$10.31

Performance

23.03%

Jeff Garro on Mar 31, 2026 assigned PHR a Overweight rating, with a price target of 20. The Buy call aligned well with market performance, producing a gain of 23.03%.

DH

Hold

Feb 27, 2026

Target

$3.00

Current

$1.05

Performance

-17.97%

On Feb 27, 2026, Jeff Garro reaffirmed DH with a Equal-Weight rating, targeting 3. The Hold stance reflected market caution that was later justified.

PRVA

Buy

Dec 04, 2025

Target

$32.00

Current

$20.42

Performance

-14.92%

PRVA was rated Overweight by Jeff Garro on Dec 04, 2025, with a price objective of 32. This case shows how bullish projections can fail, with the stock now below 20.42.

EVH

Hold

Sep 24, 2025

Target

$9.00

Current

$4.19

Performance

-56.40%

On Sep 24, 2025, Jeff Garro initiated coverage on EVH with a Equal-Weight rating and target of 9. The rating matched the stock’s inability to hold above 4.19.

SLP

Buy

Jul 15, 2025

Target

$20.00

Current

$18.42

Performance

42.02%

Jeff Garro issued a Overweight recommendation for SLP on Jul 15, 2025, price target set at 20. Investors following the Buy call captured upside momentum, with shares now at 18.42.

VEEV

Buy

Mar 06, 2025

Target

$280.00

Current

$262.40

Performance

11.12%

On Mar 06, 2025, VEEV was evaluated by Jeff Garro, who gave a Overweight rating and target of 280. This case illustrates how a timely bullish rating can translate into tangible gains of 11.12%.

ACCD

Hold

Feb 12, 2025

Target

$7.03

Current

$7.02

Performance

1.74%

Jeff Garro rated ACCD as Equal-Weight on Feb 12, 2025, setting a price target of 7.03. The Hold stance appears justified, as shares hovered around 7.02 with a 1.74% move.

MDRX

Hold

Jan 31, 2025

Target

$13.00

Current

$4.60

Performance

-15.67%

On Jan 31, 2025, MDRX was given a Equal-Weight rating by Jeff Garro, with a target price of 13. The rating provided protection from downside risk as the stock fell to 4.6.

IQV

Buy

Dec 20, 2024

Target

$250.00

Current

$261.77

Performance

32.70%

IQV received a Overweight rating from Jeff Garro on Dec 20, 2024, aiming for 250. Momentum has favored the Buy call, with shares climbing from 261.77 to 261.77, rewarding those who trusted the recommendation.

DOCS

Hold

Dec 20, 2024

Target

$55.00

Current

$25.58

Performance

-55.77%

On Dec 20, 2024, Jeff Garro published a Equal-Weight outlook on DOCS, with a target of 55. Weakness in the stock, now at 25.58, supported the conservative rating.

HNRG

Buy

Dec 09, 2024

Target

$17.00

Current

$15.34

Performance

17.82%

Jeff Garro on Dec 09, 2024 assigned HNRG a Buy rating, with a price target of 17. The Buy call aligned well with market performance, producing a gain of 17.82%.

Frequency Asked Questions

Who is Jeff Garro?

Jeff Garro is an analyst from Stephens & Co. specializing in the Healthcare sector.

What is Jeff Garro's success rate?

Jeff Garro currently has a success rate of +100.00%.

How many ratings has Jeff Garro issued?

Jeff Garro has issued 13 stock ratings so far.

What is the average return of Jeff Garro's calls?

Their stock ratings have generated an average return of +46.40%.

What is Jeff Garro's ranking?

Jeff Garro is ranked #248 out of 4773 analysts.

What types of ratings does Jeff Garro give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Jeff Garro?

You can follow Jeff Garro by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Jeff Garro?

Their latest rating was a Hold on OPRX issued on 2026-05-13.